AI Insight
A US drug advisory committee has recommended approval for several experimental peptide compounds that are being marketed as wellness products. These peptides have not undergone large-scale human clinical trials to verify their safety and efficacy. The article raises concerns about the approval of these substances without robust scientific evidence from comprehensive human testing.
Why it matters
This trend highlights a potential gap in regulatory oversight where wellness products may reach consumers without adequate scientific validation. The lack of large-scale human trials means the actual benefits, risks, and side effects of these peptides remain largely unknown to the general public using them.
Understand the Science
A drug advisory committee in the US has recommended approval for several experimental peptides. But there have been no large-scale tests of these new compounds in humans, finds columnist Grace Wade
Source: Peptides are the latest wellness trend – but do they work?